Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114628) titled 'Effect of behavioral interventions to reduce exposure to endocrine disrupting chemicals on Weight Loss in overweight or obese adults treated with semaglutide: a randomized controlled trial' on Dec. 16, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of University of Science and Technology of China
Condition:
overweight/obesity
Intervention:
contro group:Health education only
Recruitment Status: Not Recruiting
Phase: 3
Date of First Enrollment: 2026-01-01
Target Sample Size: contro group:36;Intervention group:36;
Countries of Recruitment...